1. Home
  2. BOLD vs KTCC Comparison

BOLD vs KTCC Comparison

Compare BOLD & KTCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • KTCC
  • Stock Information
  • Founded
  • BOLD 2018
  • KTCC 1969
  • Country
  • BOLD United States
  • KTCC United States
  • Employees
  • BOLD N/A
  • KTCC N/A
  • Industry
  • BOLD
  • KTCC Electrical Products
  • Sector
  • BOLD
  • KTCC Technology
  • Exchange
  • BOLD Nasdaq
  • KTCC Nasdaq
  • Market Cap
  • BOLD 49.5M
  • KTCC 41.4M
  • IPO Year
  • BOLD 2024
  • KTCC N/A
  • Fundamental
  • Price
  • BOLD $1.96
  • KTCC $3.16
  • Analyst Decision
  • BOLD Buy
  • KTCC
  • Analyst Count
  • BOLD 3
  • KTCC 0
  • Target Price
  • BOLD $22.50
  • KTCC N/A
  • AVG Volume (30 Days)
  • BOLD 50.0K
  • KTCC 41.6K
  • Earning Date
  • BOLD 04-03-2025
  • KTCC 02-04-2025
  • Dividend Yield
  • BOLD N/A
  • KTCC N/A
  • EPS Growth
  • BOLD N/A
  • KTCC N/A
  • EPS
  • BOLD N/A
  • KTCC N/A
  • Revenue
  • BOLD N/A
  • KTCC $514,394,000.00
  • Revenue This Year
  • BOLD N/A
  • KTCC N/A
  • Revenue Next Year
  • BOLD N/A
  • KTCC N/A
  • P/E Ratio
  • BOLD N/A
  • KTCC N/A
  • Revenue Growth
  • BOLD N/A
  • KTCC N/A
  • 52 Week Low
  • BOLD $1.95
  • KTCC $3.03
  • 52 Week High
  • BOLD $15.24
  • KTCC $6.14
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • KTCC 33.87
  • Support Level
  • BOLD N/A
  • KTCC $3.03
  • Resistance Level
  • BOLD N/A
  • KTCC $3.30
  • Average True Range (ATR)
  • BOLD 0.00
  • KTCC 0.20
  • MACD
  • BOLD 0.00
  • KTCC -0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • KTCC 13.83

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About KTCC Key Tronic Corporation

Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.

Share on Social Networks: